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Background: Health system planners aim to pursue the three goals of Triple Aim: 1) reduce health care costs;
2) improve population health; and 3) improve the care experience. Moreover, they also need measures that can
reliably predict future health care needs in order to manage effectively the health system performance. Yet few
measures exist to assess Triple Aim and predict future needs at a health system level. The purpose of this study is
to explore the novel application of a case-mix adjustment method in order to measure and help improve the Triple
Aim of health system performance.
Methods: We applied a case-mix adjustment method to a population-based analysis to assess its usefulness as a
measure of health system performance and Triple Aim. The study design was a retrospective, cohort study of adults
from Ontario, Canada using administrative databases: individuals were assigned a predicted illness burden score
using a case-mix adjustment system from diagnoses and health utilization data in 2008, and then followed forward
to assess the actual health care utilization and costs in the following year (2009). We applied the Johns Hopkins
Adjusted Clinical Group (ACG) Case-Mix System to categorize individuals into 60 levels of healthcare need, called
ACGs. The outcomes were: 1) Number of individuals per ACG; 2) Total system costs per ACG; and 3) Mean cost per
person per ACG, which together formed a health system “dashboard”.
Results: We identified 11.4 million adults. 16.1% were aged 65 or older, 3.2 million (28%) did not use health care
services that year, and 45,000 (0.4%) were in the highest acuity ACG category using 12 times more than an average
adult. The sickest 1%, 5% and 15% of the population use about 10%, 30% and 50% of total health system costs
respectively. The dashboard measures 2 dimensions of Triple Aim: 1) reduced costs: when total system costs per
ACG or when average costs per person is reduced; and 2) improved population health: when more people move
into healthier rather than sicker ACGs. It can help to achieve the third aim, improved care experience, when ACG
utilization predictions are reported to providers to proactively develop care plans.
Conclusions: The dashboard, developed via case-mix methods, measures 2 of the Triple Aim goals and can help
health system planners better manage their health delivery systems.
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Health system planners and policymakers are responsible
for managing health system performance, and thus review
quality indicators as well as assessments of the current ill-
ness burden in the population so as to help predict the fu-
ture need for health care services. They need to use existing
data to help them first measure health system performance,
and second improve the quality of the health system, such
as where to implement particular quality improvement
activities. The Institute of Healthcare Improvement, an
organization that is a leader of quality improvement and
performance measurement at the health system level [1-4],
has espoused the seminal concept that high performing
health systems ought to pursue the Triple Aim: to 1) reduce
health care costs; 2) improve population health; and 3) im-
prove the care experience [5]. Within the U.K and U.S. es-
pecially, the Triple Aim has grown in popularity because
new health care reforms, such as the NHS Outcomes
Framework and the Affordable Care Act respectively, have
broad goals of improving health system performance, such
as improving quality, equity and access, but also include
the three goals of the Triple Aim.
Within the past decade, many health system perform-
ance frameworks have been developed [6-23], comprised
of various quality indicators, some of which relate to the
Triple Aim goals. For example, quality indicators related
to health system costs include health expenditures per
capita [19], 30 day acute care readmissions [21], and pre-
ventable hospitalizations [22]. Population health has
been assessed through indicators such as life expectancy,
disability-adjusted life year [19], obesity rates in children,
and the percentage of adults who smoke [22]. Care ex-
perience has been demonstrated by indicators such as
the rate of adverse events, timely access to primary care,
and wait times for surgery. On the one hand, the exist-
ing quality indicators have been useful to improve qual-
ity within particular populations because many of them
are often disease-focused, setting-specific, or based on
one episode of care. They have a well-defined denomin-
ator and thus a particular process of care or group of
providers that can be held accountable to improve the
rates. On the other hand, these measures are limited in
other ways. They typically do not capture performance
of the broader health care system, including care across
different providers and settings throughout the con-
tinuum of care. As such current measures especially do
not serve well patients with multiple comorbidities who
represent the most expensive and medically-complex
users of the system [24-26]. Thus it remains a challenge
to measure the broader system performance, with re-
spect to the Triple Aim.
Not only do planners want to measure Triple Aim and
health system performance effectively, but want to do so in
efficient and simple ways that can aid quality improvement.Health system planners and policymakers often use visual
dashboards to integrate and compile important quality in-
dicators and other key performance indicators into one
place. An effective dashboard can help them to easily ac-
cess and analyze important trends from the indicators, sup-
porting timely decision-making and quality improvement.
While other dashboards of health system performance
exist, to our knowledge, no dashboards exist that measure
the Triple Aim. Moreover, little research has explored how
health system planners might use such as dashboard to aid
quality improvement activities and help achieve the Triple
Aim. The purpose of this study is to develop a visual dash-
board, based on a case-mix adjustment method, and ex-
plore its applicability to measure and help improve health
system performance, with respect to the Triple Aim.
Methods
We conducted a retrospective, population-based, cohort
study of adults from Ontario, Canada using multiple ad-
ministrative databases. To develop the dashboard gener-
ally, individuals were assigned a predicted illness burden
score using a case-mix adjustment system from diagno-
ses and health utilization data occurring in fiscal year
2007–08, and then followed forward to assess the actual
health care utilization and costs in the following year
(fiscal year 2008–09).
Specifically, we identified a cohort of unique Ontarians
with a valid Ontario Health Insurance Plan number, the
universal provincial health insurance plan, who were
alive on April 1, 2008 and deterministically linked with
the other administrative databases [27-32]. We excluded
children aged younger than 18 to simplify the analysis.
Using the previous fiscal year’s administrative data
(FY2007-08), we applied the Johns Hopkins Adjusted
Clinical Group (ACG) Case-Mix System (version 7) in
this cohort to categorize individuals into mutually exclusive
levels of healthcare need, called ACGs. Then using the sub-
sequent fiscal year’s administrative data (FY2008-09), we
determined the actual health care utilization and costs for
each individual during that year. In doing so, this method-
ology aims to demonstrate the value of the dashboard to
predict future costs and utilization, based on previous
utilization and illness burden.
Setting
In Ontario, Canada, because of the mainly single-payer
nature of the health care financing system, the govern-
ment collects a large amount of administrative health
care data that can be used for research purposes. The
provincial Ministry of Health and Long-Term Care pro-
vides funding for all Ontarians for hospital and physician
services free at the point of care, with other services
heavily subsidized. As such, Ontario’s Ministry of Health,
in some ways, can be viewed as a large health insurer
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Data Sources
The Registered Persons Database was the source for valid
health insurance number, age (at start of FY), and sex. The
Discharge Abstract Database, maintained by the Canadian
Institute of Health Information, contained data for all hos-
pital in-patient admissions and length of stay. The National
Ambulatory Care Reporting System contained data for all
emergency department (ED) and hospital and clinic out-
patient visits. Finally, the Ontario Health Insurance Plan
Claims database contained information on physician claims
and ancillary services (e.g. laboratory work, blood tests).
The ACG case-mix system
The Johns Hopkins ACG system is a diagnosis-based,
case-mix method that uses administrative data to pre-
dict a population’s current and future healthcare need,
healthcare use, and costs in one to two years. It cap-
tures the clinical complexity of multiple comorbidities
without being disease-specific. ACGs have traditionally
been used for risk-adjusted reimbursement and practi-
tioner profiling in the US [33-37], Canada, and inter-
nationally [29,38-44]. The method uses each person’s
inpatient and outpatient diagnosis codes, age, and sex
to assign individuals into 32 Ambulatory Diagnosis
Groups (ADGs) — the building blocks of the ACGs.
ADGs are unique in that they do not group by disease,
but instead based on clinical similarities in need and
expected resource use. Because people can have mul-
tiple chronic conditions, ADGs are not mutually ex-
clusive. For example, ADG1 represents “time limited:
minor conditions” (e.g. bell’s palsy or diaper rash),
whereas ADG24 represents “injuries/adverse effects:
major” (e.g. lower limb fractures or intracranial in-
jury). Second, the methodology groups ADGs into 60
commonly occurring combinations, which are mutu-
ally exclusive ACG groups. Examples of ACG groups
range from relatively small needs, such as “acute
minor” (e.g. ear infection or cold), to the most expen-
sive, “10+ ADG combinations, 4+ major ADGs” (e.g.
multiple, unstable, chronic conditions with acute com-
plications) [43].
The dashboard
At the individual-level, based on FY2007-08 administra-
tive data, every adult was categorized into an ACG, and
their subsequent year’s health care utilization and costs
from FY2008-09 were determined. Our results were ag-
gregated into sub-populations of ACG categories, and the
all 60 ACGs collectively represent all adults in the prov-
ince. Specifically, we analyzed and presented our data tocreate 3 figures, which we refer to as a health system
“dashboard”. The dashboard’s 3 figures describe the:
1) Number of individuals in each ACG;
2) Total system costs for each ACG; and
3) Mean cost per person for each ACG.
We applied a costing methodology that has been vali-
dated previously that includes health utilization costs of
only hospitalizations, ED visits, physician claims and an-
cillary services claims that were publicly financed by the
Ontario government [45-47]. Thus, the dashboard repre-
sents the past illness burden, utilization, health system
costs, as well as the predicted health care use of the en-
tire population profile or of any particular ACG cat-
egory. We created a dashboard for the overall province.
Besides ACG categories, health care need was also
quantified using ACG utilization weights, calibrated to
Ontario data [43]. A utilization weight for each ACG rep-
resents the multiplier of expected resource use relative to
the population’s mean expenditures. By definition, the
average ACG weight was 1.0 for the entire population.
Thus, an ACG weight of 2.0 represents a two-fold increase
in expected healthcare utilization in the subsequent year.
Note the dashboard is sorted from lowest to highest ACG
weight, which corresponds to lowest to highest predicted
healthcare need. Furthermore, we sorted our ACG cat-
egories into resource utilization quintiles based on the
ACG weights. Higher quintiles were associated with
higher expected utilization levels. All individuals in a given
quintile were expected to use approximately the same
amount of care. Non-users were excluded from the quin-
tiles and assigned a zero value. This study was reviewed
by the ethics committee of the Sunnybrook Health Sci-
ence Centre and deemed exempt research, as it uses de-
identified secondary data analysis.Results
Our provincial analysis of Ontario in FY2008-2009
identified 11.4 million adults. Nearly half of the cohort
was female and 16.1% were aged 65 or older. (Table 1)
Approximately 3.2 M (28%) did not use the healthcare
system or had services with unclassified diagnoses
(ACG = 5100); their average ACG weight was 0.17.
Conversely, 45,383 adults (0.4%) were categorized into
the highest average ACG weight of 12.61 (ACG = 5070).
Figures 1A-1C comprise the provincial dashboard.
Figure 1A displays the distribution of number of adults
who are categorized in the various ACG categories. The
second largest ACG category is adults older than 34
who are expected to have acute minor issue(s) (e.g. ear in-
fections, sore throats, etc.), comprising 10.9% of the popu-
lation (ACG= 4100). In the lower 4 resource utilization
Table 1 Cohort demographics and ACG assignment by ACG weight




Female 5,894,366 51.8 1.08
Male 5,496,719 48.3 0.92
Age
19-34 3,221,862 28.3 0.56
35-44 2,408,590 21.1 0.7
45-54 2,303,950 20.2 0.95
55-64 1,626,276 14.3 1.26
65-74 979,727 8.6 1.72
75-84 623,531 5.5 2.3
85+ 227,149 2 2.48
ACGs, sorted by lowest to highest illness severity weight
5100 No or Only Unclassified Diagnoses & Non-Users 3,189,204 28 0.17 0
1600 Preventive/Administrative 185,342 1.6 0.33 1
600 Likely To Recur, with Allergies 28,658 0.3 0.36 1
700 Asthma 20,604 0.2 0.37 1
300 Acute Minor, Age 6+ 633,452 5.6 0.38 1
500 Likely To Recur, without Allergies 282,943 2.5 0.39 1
2200 Acute Minor: Age > 5,with Allergy 38,494 0.3 0.44 1
400 Acute: Major 407,466 3.6 0.49 1
2100 Acute Minor: Age > 5,w/out Allergy 289,867 2.5 0.49 2
3900 Acute Minor: Male, Age 18-34 106,375 0.9 0.51 2
1300 Psychosocial, without Psychosocial Unstable 124,842 1.1 0.53 2
1200 Chronic Specialty, Unstable 17,645 0.2 0.55 2
1000 Chronic Specialty 6,545 0.1 0.58 2
1800 Acute Minor and Acute Major 404,069 3.6 0.59 2
2800 Acute Major And likely To Recur 189,580 1.7 0.6 2
2400 Acute Minor and Eye/Dental 9,620 0.1 0.6 2
2500 Acute Minor, Psychosocial, Without Unstable 94,404 0.8 0.61 2
1100 Ophthalmological/Dental 17,678 0.2 0.62 2
3300 Acute Minor: Age > 12, with Allergies 44,122 0.4 0.67 2
4000 Acute Minor: Female, Age 18-34 108,935 1 0.73 2
900 Chronic Medical, Stable 311,434 2.7 0.76 2
3200 Acute Minor: Age > 12,w/out Allergies 327,428 2.9 0.76 3
3400 Acute Minor/Likely To Recur/Eye & Dental 6,164 0.1 0.77 3
4310 4-5 Other ADG Combos, Age 18–44, No Major ADGs 162,851 1.4 0.79 3
4710 6-9 Other ADG Combos, Male, Age 18–34, No Major ADGs 6,218 0.1 0.8 3
2300 Acute Minor and Chronic Medical: Stable 191,521 1.7 0.81 3
3500 Acute Minor/Likely To Recur/Psychosocial 79,984 0.7 0.84 3
4320 4-5 Other ADG Combos, Age 18–44, 1 Major ADG 125,136 1.1 1.07 3
4100 Acute Minor: Age >34 1,245,235 10.9 1.23 3
4810 6-9 Other ADG Combos, Female, Age 18–34, No Major ADGs 19,406 0.2 1.25 4
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Table 1 Cohort demographics and ACG assignment by ACG weight (Continued)
1730 Pregnancy: 2–3 ADGs, 1+ Major ADGs 8,041 0.1 1.26 4
3700 Acute Minor & Major/Likely to Recur/Psychosocial 139,182 1.2 1.29 4
4720 6-9 Other ADG Combos, Male, Age 18–34, 1 Major ADGs 11,186 0.1 1.3 4
4410 4-5 Other ADG Combos, Age >44, No Major ADGs 334,873 2.9 1.31 4
3600 Acute Minor/Maj/Likely to Recur/Chronic Med:Stable 236,710 2.1 1.35 4
800 Chronic Medical, Unstable 62,924 0.6 1.41 4
1750 Pregnancy: 4–5 ADGs, 1+ Major ADGs 21,750 0.2 1.49 4
4820 6-9 Other ADG Combos, Female, Age 18–34, 1 Major ADG 22,384 0.2 1.61 4
1710 Pregnancy: 0–1 ADGs 15,661 0.1 1.66 4
4330 4-5 Other ADG Combos, Age 18–44, 2+ Major ADGs 29,298 0.3 1.67 4
2600 Acute Minor: Unstable without Stable 10,486 0.1 1.69 4
1400 Psychosocial, with Unstable, without Stable 26,273 0.2 1.76 4
1720 Pregnancy: 2–3 ADGs, No Major ADGs 68,678 0.6 1.76 4
2700 Acute Minor: with Unstable & Stable 6,908 0.1 1.84 4
1500 Psychosocial, with Unstable and Stable 10,742 0.1 1.84 4
1740 Pregnancy: 4–5 ADGs, No Major ADGs 61,586 0.5 1.86 4
1770 Pregnancy: 6+ ADGs, 1+ Major ADGs 40,171 0.4 2.05 5
1760 Pregnancy: 6+ ADGs, No Major ADGs 34,666 0.3 2.13 5
4420 4-5 Other ADG Combos, Age >44, 1 Major ADGs 404,582 3.6 2.16 5
4910 6-9 Other ADG Combos, Age >34, 0–1 Major ADGs 507,762 4.5 2.3 5
4830 6-9 Other ADG Combos, Female, Age 18–34, 2+ Major ADGs 10,758 0.1 2.68 5
4730 6-9 Other ADG Combos, Male, Age 18–34 2+ Major ADGs 9,737 0.1 2.76 5
5040 10+ Other ADG Combos, Age 18+, 0–1 Major ADGs 33,410 0.3 3.11 5
4430 4-5 Other ADG Combos, Age >44, 2+ Major ADGs 136,748 1.2 3.29 5
4920 6-9 Other ADG Combos, Age >34, 2 Major ADGs 237,874 2.1 3.94 5
5050 10+ Other ADG Combos, Age 18+, 2 Major ADGs 43,637 0.4 5.08 5
4930 6-9 Other ADG Combos, Age >34, 3 Major ADGs 83,427 0.7 5.72 5
5060 10+ Other ADG Combos, Age 18+, 3 Major ADGs 42,381 0.4 7.45 5
4940 6-9 Other ADG Combos, Age >34, 4+ Major ADGs 18,533 0.2 7.9 5
5070 10+ Other ADG Combos, Age 18+, 4+ Major ADGs 45,383 0.4 12.61 5
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average adult.
Figure 1B displays the total provincial health system
costs in Canadian dollars for all adults within each of
the ACG categories, totalling $15.8B of direct costs from
hospital, fee-for-service physician and ancillary service
billing, and ED services. Based on ACG weights, the
sickest 1%, 5% and 15% of the adult population will use
about 10%, 30% and 50% of total health system costs re-
spectively. The largest 5 ACG categories with the most ag-
gregate costs to the health system are: acute minor issues
for adults >34 (ACG= 4100); 0–1 major ADG, age >34, and
6–9 other ADG combinations (ACG= 4910); 2 major ADG,
age >34, and 6–9 other ADG combinations (ACG= 4920); 1
major ADG, age >44, and 4–5 other ADG combinations
(ACG= 4420); and the 4+ major ADGs, age > 18, and 10+other ADG combinations (ACG= 5070). Health system
costs directly relate to both the number of adults within
each group and the severity of the adults’ conditions. Hos-
pital services comprise the largest percentage of cost within
each ACG, followed by physician services. ED costs com-
prise a very small fraction of total costs within each ACG.
Figure 1C displays the average cost per category
(weight = 12.6) was $17,271. The average yearly cost per
adult (ACG weight of 1) was $1,382. Similar to total sys-
tem costs, hospital services comprise the largest percent-
age of costs.
Discussion
Our study applied a case-mix and costing method to a large
population-based sample to analyze the predicted health
care needs, and then follow that population to calculate the
Figure 1 Using the dashboard to help measure the Triple Aim.
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health system dashboard of the sickest and highest cost
users in the system, which acts as one measure of health
system performance. Unsurprisingly, the sickest and most
expensive adults had multiple major illnesses and multiple
combinations of comorbidities. Similar to the US, a small
percentage of our Ontarian study population (15%) use a
disproportionate amount of the total health care system
costs (48%).
The dashboard can help to partially measure the Triple
Aims
We propose that the dashboard can measures 2 of the 3
dimensions of the Triple Aim, namely health system costsFigure 2 Using the dashboard to help achieve the Triple Aim.and population health. (Figure 2) First, the dashboard in-
dicates lower system costs over time when the cost curve
in Figure 2C shifts to the left (so average health costs/per-
son are less) or when any ACG category in Figure 2B is
shortened (so total system costs for an ACG category is
reduced). Second, the dashboard indicates a healthier
population over time when the healthcare utilization
curve in Figure 2A shifts upwards (more people move up-
wards into ACG categories with less healthcare use) rather
than downwards (more healthcare use). While past and
predicted healthcare utilization is a proxy for population
health, we recognize it does not truly capture all aspects
of health, such as quality of life. Nonetheless, measure-
ment of the Triple Aim, even partially, is important.
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the Triple Aims
In addition to measurement, we also propose that the
dashboard’s information can support health system plan-
ners to manage their health delivery systems more effect-
ively. The dashboard represents a profile of the illness
burden and healthcare needs of a population at a given
time, and is thus a useful tool to predict the need for fu-
ture healthcare services. By using this data, planners and
providers can proactively intervene with appropriate pol-
icy, programs, and clinical and social interventions for the
highest risk patients or the patients who are most likely to
benefit so that ideally the same population is healthier the
next time the dashboard is measured. Thus, the dashboard
would need to be reported regularly (e.g. quarterly or bi-
annually) in a continual feedback loop to indicate changes
over time. Using the dashboard in this way would be sup-
ported by evidence that show the effectiveness health sys-
tem measures depends on the extent that it reflects the
goals of the health system, the quality of the data, and the
incentives for providers to scrutinize and act on the data
[48]. Below, we provide an example of how the dashboard
could be used at various levels to support the achievement
of the Triple Aim.
 Reduce costs: First, to achieve lower system costs
and move the cost curve left, (See Figure 2C)
policymakers and providers could use the dashboard
to support cost-effective improvements in care (e.g.
new technologies, diagnostic equipment, or surgical
techniques), such as in ACGs with many individuals
even if they are not the most complex cases. The
dashboard might also identify medical provider
specialties that ought to be high priority for better
alignment with financial incentives that focus on
patient outcomes or bundles of care, rather than
number of visits, as in fee-for-service. Second,
policymakers and providers can act to reduce costs
within individual ACG categories. For highest-needs
or highest-costs individuals, they could support
interventions that provide patients with additional
care support, intensive case management, or early
referral to palliative care as appropriate, all of which
can avoid unnecessary hospitalizations and ED visits.
For medium- and low-risk individuals, they could
support interventions that maintain or improve
health, such as self-care, healthy nutrition, exercise,
and wellness programs, which can reduce costs
within an ACG category. (See Figure 2B)
 Improve population health: The dashboard can
present data to providers at an individual or group
practice level about their patient rosters to
determine if their roster is getting healthier over
time (See Figure 2A). Providers and policymakerscould use the information to focus on particular
health conditions, regions, or populations that could
benefit from targeted interventions, and the size and
scale required for such interventions. For the sickest
population, they could refer them to interventions
or supports that prevent the worsening of their
condition (e.g. falls prevention), or help them
manage complex conditions (e.g. intensive case
management or nurse coaching). Just as importantly,
for the medium and low-risk population, providers
could encourage interventions that promote prevention
and wellness, improve health, and reverse the disease
progression, such as self management and exercise
programs.
 Improve patient care experience: The dashboard
does not measure care experience directly. However,
the dashboard’s information potentially can help
providers improve care experience and overall
health. For instance, the dashboard could report to
providers the high-risk, medically complex patients
they are the most responsible physician for. The
providers could then work proactively, rather than
reactively, to intervene and develop multidisciplinary
care plans for higher need individuals to prevent
worsening of the condition(s) rather than wait for
them to arrive in the hospital or their office with an
issue. Thus the dashboard can support integration
with the broader health system and health care team
to improve the care experience for the patient.
The dashboard marries both an economic analysis
with a case-mix adjustment analysis to help user predict
future costs in relation to predicted illness burden and
health care needs. When the dashboard is compared
over multiple time periods, it can provide a dynamic tool
to help measure population health and health system
performance. A key strength of the dashboard is that it
can be adapted to profile multiple populations: it could
be presented at a macro level (e.g. NHS regional teams
or state Medicaid insurance program) for high-level
planning and resource allocation, but could also be use-
ful at a micro level (e.g. small health region, community,
or small group practice) where sample sizes are small
enough for health care providers to assume responsibil-
ity for patients in an ACG. Moreover, the dashboard can
be adapted to present data by age (e.g. children), by dis-
ease or condition (e.g. cancer or heart disease), by geog-
raphy, income, etc. Thus disease specific organizations,
or community programs that focus on particular ages or
needs, can also use a similar methodology to target high
risk patients, as well as track impact and improvement on
the population’s health. The dashboard relies on case-mix
methods, which have the advantage of typically relying on
existing administrative data already available. Moreover,
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profiles, connect across multiple sectors, and compare
across regions to allow for a broader health system assess-
ment. Finally, the dashboard is not constrained by the
ACG case-mix method. Other case-mix methodologies
could be applied in a similar way to population-based
samples.
The dashboard could be useful to policymakers, health
system planners, and providers for measuring health sys-
tem performance, especially in countries with largely
single payer health systems, such as in Canada, UK, or
other European Union countries. Many federally and re-
gionally funded programs could report this dashboard in-
dicator publically and regularly in order to manage
region-wide initiatives and to facilitate quality improve-
ment. In the US, the dashboard would be especially useful
in “closed” group model systems or capitated managed
care organizations, where they provide comprehensive
care team is within the same health delivery system, so
care information such as medical records can be shared
easily. It would also be useful in open group models, be-
cause the dashboard is not setting specific and can sup-
port providers to better coordinate and integrate care
across settings and providers.
While the dashboard might be unique and useful, it
needs further development in applicability and account-
ability. We did not explore the ACG categories by pro-
vider practice group, by region, by children versus adult,
or by disease type, though have planned other subsequent
research to do this. The costing methodology could be
more comprehensive and inclusive, and does not include
privately obtained services. Cost and utilization by ACG
does not determine quality of care. Case-mix measures
are dependent on observed morbidity and provider diag-
nostic coding, which may be biased by unobserved mor-
bidity and coding behaviours [49]. Moreover, we have yet
to explore the predictive nature of the dashboard for dif-
ferent outcomes from one year to the next. This paper
showed a snapshot of one year, and did not explore the
true dynamic nature of the dashboard over multiple time
periods. Prior research has shown the ACGs alone are
predictive of 40% of same year’s and 14% of next year’s
total costs [42]. Other versions of the ACG system include
prescription drugs when assigning categories, which might
improve predictive ability, though this was not done in
this study. Further research that combines ACG data with
other administrative data, such as clinical, health behavior,
drug data, or survey data about quality of care, may in-
crease its predictive ability and should be explored.
The application of case-mix methodology to administra-
tive, population based data is not novel. In the public do-
main, many research studies applied ACGs to various
populations for the purposes of case-mix adjustment and
reimbursement, practice variation, provider profiling, andthe management of disease populations [33-37,50]. How-
ever, these studies do not aim to indicate health system
performance with respect to the Triple Aim. In the propri-
etary domain, many managed care organizations and
health insurers in the US, responsible for healthcare deliv-
ery to large populations, have likely adapted various case-
mix methods to predict future expenditures and to meas-
ure health system performance, at least in the populations
they serve. However, to our knowledge, the results of such
analyses, especially the costing data, have not been made
publicly available due to proprietary nature of the data.
We believe this dashboard is a unique contribution in that
it applies a standard case-mix approach—commonly used
for confidential reimbursement, insurance rate setting,
and practitioner profiling—in a way that can be used by
health system planners to measure health system perform-
ance and inform quality improvement activities, whether
organizations choose to make the data public or not. To
measure more dimensions of the Triple Aim and health
system performance more broadly, the dashboard should
be integrated and used in combination with other quality
measures.
Conclusion
In summary, the health system performance dashboard, de-
veloped via case-mix methods, can help policymakers, plan-
ners, and providers better manage their health delivery
systems because it measures two of three of the Triple Aim
goals at a system level. Moreover, when fed back appropri-
ately to providers and policymakers, the health system per-
formance dashboard has the potential to support appropriate
resource allocation and related quality improvement in the
system and ultimately help to achieve the Triple Aim.
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